Added to YB: 2026-09-18
Pitch date: 2026-09-15
HITI [neutral]
High Tide Inc.
Author Info
No bio for this author
Company Info
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally.
Market Cap
CAD 324.2M
Pitch Price
N/A
Price Target
5.20
Dividend
N/A
EV/EBITDA
7.84
P/E
-9.32
EV/Sales
0.59
Sector
Pharmaceuticals
Category
growth
High Tide: record results, improving cash flow, 41% upside and one German regulatory risk standing in the way.
HITI (earnings): High Tide delivered a record fiscal Q3, with revenue up 33% to $198.8m and adjusted EBITDA up 53% to $16.2m, but most growth and margin expansion came from acquired German distributor Remexian while same-store sales were flat. The C$5.20 target offers 41% upside from C$3.69, but the C$48.4m Remexian put, weak governance and German regulatory uncertainty are material risks; despite the buy rating, that regulatory uncertainty prevents taking a position.
Read full article (9 min)